SELL and metabolic dysfunction-associated steatohepatitis: Notably, PMNs of NASH patients displayed a significant decrease in CD62L expression levels and a significant increase in CD11b respect to healthy donors and NAFL patients (Figure 3(b), representative flow cytometry gating strategy showed in Supplementary Figure S3).